Praxis Precision Medicines PRAX
NASDAQ PRAX
$257.52 +1.05 (+0.41%)
As of: Oct 22, 2026 · 10:21 AM EDT

Praxis Precision Medicines (PRAX) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Praxis Precision Medicines' Net Equity Issued and Repurchased came in at $4.88 million for Q2 2026, compared with $294,000 a year earlier and up 336.3% from the prior quarter.

Analysis

Praxis Precision Medicines (PRAX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Praxis Precision Medicines reported Net Equity Issued and Repurchased of $18.42 million, up 508.2% year-over-year; for FY2025, it came in at $13.27 million, up 404.1% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -41.9% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $2.63 million in FY2024 (+532.9%), $416,000 in FY2023 (-70.8%), $1.43 million in FY2022 (-98.6%) and $98.41 million in FY2021 (-51.0%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is $1,000 (Q3 2023) to $96.45 million (Q4 2021).
  • Year-over-year, Net Equity Issued and Repurchased increased in four of the last five quarters, with growth averaging 235.0%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2025 (growth of 488.2%), and the weakest in Q4 2022 (a decline of 99.8%).
  • Business Quant data shows PRAX's Net Equity Issued and Repurchased at $1.12 million (Q1 2026), $11.61 million (Q4 2025) and $808,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn 138.00 Mn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn -9.00 Mn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn -
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn -
10 Praxis Precision Medicines 7.52 Bn 5.11 Bn - 4.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.88 Mn
Mar 31, 2026 1.12 Mn
Dec 31, 2025 11.61 Mn
Sep 30, 2025 808,000.00
Jun 30, 2025 294,000.00
Mar 31, 2025 560,000.00
Dec 31, 2024 1.97 Mn
Sep 30, 2024 201,000.00
Jun 30, 2024 315,000.00
Mar 31, 2024 143,000.00
Dec 31, 2023 106,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 208,000.00
Mar 31, 2023 101,000.00
Dec 31, 2022 163,000.00
Sep 30, 2022 410,000.00
Jun 30, 2022 520,000.00
Mar 31, 2022 333,000.00
Dec 31, 2021 98.89 Mn
Sep 30, 2021 308,000.00
API Access

Praxis Precision Medicines Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PRAX&period=max&api_key=YOUR_API_KEY